On March 25, the "Innovative macromolecular Drug Research and Development Center" of Aoke Immune was unveiled in Nanjing Jiangning High-tech Zone. Party Secretary Han Liming met with Liu Yang, founder and chairman of Anco Immunology.
Han Liming congratulated on the opening of the R&D center and briefly introduced the development of Nanjing's biomedical industry.
Biomedicine is an important field to accelerate the formation of new quality productivity. Nanjing has relatively rich scientific and educational resources, industrial foundation and certain first-mover advantages. We hope that Angke Immune can give full play to its innovation ability in immunotherapy and other fields, and cooperate closely with relevant universities, medical institutions and enterprises in Nanjing to accelerate the implementation and transformation of innovative drugs. At the same time, more industrial chain ecosystem enterprises will be attracted to settle in Nanjing to achieve a higher level of mutual benefit and win-win. Nanjing will continue to create a good industrial innovation ecology and provide a first-class environment and support for enterprises to grow bigger and stronger.
Liu Yang said that Nanjing is rich in science and education talent resources, pragmatic and efficient service enterprises, and the project has progressed smoothly since it settled in Nanjing, so that we are full of confidence in the future development. Angke Immunology will continue to increase its investment layout in Ning, and strive to play a greater role in the strong chain of Nanjing biomedical industry cluster.
"Innovative Macromolecular Drug Research and Development Center" is the research and development center and future industrialization base of Onco Immunity in China, mainly responsible for Phase III clinical trials of new generation anti-CTLA-4 monoclonal antibody innovative drugs, and will be industrialized in the park in the future.
City leaders Jiang Yuejian, Lin Tao, the founder of Aoke immunity Zheng Pan and other participants.
Content source: Nanjing Daily/Zijinshan News reporter Zou Wei
